Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Dec 1;320(Pt 2):437–444. doi: 10.1042/bj3200437

Heparin-decasaccharides impair the catabolism of chylomicrons.

O Chevreuil 1, M Hultin 1, P Ostergaard 1, T Olivecrona 1
PMCID: PMC1217949  PMID: 8973550

Abstract

On intravenous injection to rats, decasaccharides gave rise to a short-lived peak of lipoprotein lipase (LPL) activity, whereas octa- and hexasaccharides caused only marginal increases. In isolated hearts perfused by a single pass, decasaccharides released LPL more efficiently than conventional heparin on a mass basis. Octa- and hexasaccharides were much less efficient. Similar results were obtained for hepatic lipase, which was studied both in vivo and by liver perfusion. In the intact rat, the heparin fragments themselves disappeared rapidly from the circulating blood. The decay of hepatic lipase activity after the early peak roughly paralleled the decay of decasaccharide concentration, but for LPL the decay was faster, presumably because the liver extracted this lipase from plasma. To assess the lipase activities remaining in contact with blood a large dose of conventional heparin was injected at a series of times after the decasaccharides. LPL was decreased by 40% after 1 h. At that time, the LPL activity that could be released from isolated hearts by single-pass perfusion with heparin for 2 min ("functional LPL') was decreased by 75%. Chylomicrons labelled in vivo with [14C]oleic acid (primarily in triacylglycerols, providing a tracer for lipolysis) and [3H]retinol (primarily in ester form, providing a tracer for the particles) were injected intravenously to explore the effects of the LPL depletion on lipoprotein metabolism. Triacylglycerol lipolysis and particle clearance was markedly delayed from 30 min to 2 h after injection of decasaccharides. After 1 h the fractional catabolic rate was only one-third of the control value and the catabolism of chylomicron triacylglycerols by perfused hearts was delayed to a similar extent. Thus injection of decasaccharides leads to accelerated turnover of LPL with loss of functional LPL from extrahepatic tissues. This in turn leads to a period of delayed lipolysis and removal of chylomicron particles.

Full Text

The Full Text of this article is available as a PDF (636.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagby G. J. Heparin-independent release of lipoprotein lipase activity from perfused rat hearts. Biochim Biophys Acta. 1983 Aug 29;753(1):47–52. doi: 10.1016/0005-2760(83)90096-6. [DOI] [PubMed] [Google Scholar]
  2. Bengtsson G., Olivecrona T., Hök M., Riesenfeld J., Lindahl U. Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J. 1980 Sep 1;189(3):625–633. doi: 10.1042/bj1890625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braun J. E., Severson D. L. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin. Lipids. 1993 Jan;28(1):59–61. doi: 10.1007/BF02536362. [DOI] [PubMed] [Google Scholar]
  4. Chajek-Shaul T., Bengtsson-Olivecrona G., Peterson J., Olivecrona T. Metabolic fate of rat heart endothelial lipoprotein lipase. Am J Physiol. 1988 Sep;255(3 Pt 1):E247–E254. doi: 10.1152/ajpendo.1988.255.3.E247. [DOI] [PubMed] [Google Scholar]
  5. Chajek-Shaul T., Friedman G., Ziv E., Bar-On H., Bengtsson-Olivecrona G. Fate of lipoprotein lipase taken up by the rat liver. Evidence for a conformational change with loss of catalytic activity. Biochim Biophys Acta. 1988 Nov 25;963(2):183–191. doi: 10.1016/0005-2760(88)90279-2. [DOI] [PubMed] [Google Scholar]
  6. Chevreuil O., Hultin M., Ostergaard P., Olivecrona T. Biphasic effects of low-molecular-weight and conventional heparins on chylomicron clearance in rats. Arterioscler Thromb. 1993 Oct;13(10):1397–1403. doi: 10.1161/01.atv.13.10.1397. [DOI] [PubMed] [Google Scholar]
  7. Chevreuil O., Hultin M., Ostergaard P., Olivecrona T. Depletion of lipoprotein lipase after heparin administration. Arterioscler Thromb. 1993 Oct;13(10):1391–1396. doi: 10.1161/01.atv.13.10.1391. [DOI] [PubMed] [Google Scholar]
  8. Doolittle M. H., Wong H., Davis R. C., Schotz M. C. Synthesis of hepatic lipase in liver and extrahepatic tissues. J Lipid Res. 1987 Nov;28(11):1326–1334. [PubMed] [Google Scholar]
  9. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  10. Hamilton R. L., Berry M. N., Williams M. C., Severinghaus E. M. A simple and inexpensive membrane "lung" for small organ perfusion. J Lipid Res. 1974 Mar;15(2):182–186. [PubMed] [Google Scholar]
  11. Hultin M., Bengtsson-Olivecrona G., Olivecrona T. Release of lipoprotein lipase to plasma by triacylglycerol emulsions. Comparison to the effect of heparin. Biochim Biophys Acta. 1992 Apr 8;1125(1):97–103. doi: 10.1016/0005-2760(92)90161-n. [DOI] [PubMed] [Google Scholar]
  12. Hultin M., Olivecrona G., Olivecrona T. Effect of protamine on lipoprotein lipase and hepatic lipase in rats. Biochem J. 1994 Dec 15;304(Pt 3):959–966. doi: 10.1042/bj3040959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jackson R. L., Busch S. J., Cardin A. D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991 Apr;71(2):481–539. doi: 10.1152/physrev.1991.71.2.481. [DOI] [PubMed] [Google Scholar]
  14. Johansen P. B., Rasmussen S. N., Ostergaard P. B. Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in rats. Thromb Res. 1994 Aug 15;75(4):453–464. doi: 10.1016/0049-3848(94)90260-7. [DOI] [PubMed] [Google Scholar]
  15. Larnkjaer A., Hansen S. H., Ostergaard P. B. Isolation and characterization of hexasaccharides derived from heparin. Analysis by HPLC and elucidation of structure by 1H NMR. Carbohydr Res. 1995 Jan 3;266(1):37–52. doi: 10.1016/0008-6215(94)00247-d. [DOI] [PubMed] [Google Scholar]
  16. Larnkjaer A., Nykjaer A., Olivecrona G., Thøgersen H., Ostergaard P. B. Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments. Biochem J. 1995 Apr 1;307(Pt 1):205–214. doi: 10.1042/bj3070205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Merchant Z. M., Erbe E. E., Eddy W. P., Patel D., Linhardt R. J. Effect of very low molecular weight heparin-derived oligosaccharides on lipoprotein lipase release in rabbits. Atherosclerosis. 1986 Nov;62(2):151–158. doi: 10.1016/0021-9150(86)90061-4. [DOI] [PubMed] [Google Scholar]
  18. Nielsen J. I. A convenient method for molecular mass determination of heparin. Thromb Haemost. 1992 Oct 5;68(4):478–480. [PubMed] [Google Scholar]
  19. Parthasarathy N., Goldberg I. J., Sivaram P., Mulloy B., Flory D. M., Wagner W. D. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J Biol Chem. 1994 Sep 2;269(35):22391–22396. [PubMed] [Google Scholar]
  20. Persson B., Bengtsson-Olivecrona G., Enerbäck S., Olivecrona T., Jörnvall H. Structural features of lipoprotein lipase. Lipase family relationships, binding interactions, non-equivalence of lipase cofactors, vitellogenin similarities and functional subdivision of lipoprotein lipase. Eur J Biochem. 1989 Jan 15;179(1):39–45. doi: 10.1111/j.1432-1033.1989.tb14518.x. [DOI] [PubMed] [Google Scholar]
  21. Schoonderwoerd K., Hülsmann W. C., Jansen H. Stabilization of liver lipase in vitro by heparin or by binding to non-parenchymal liver cells. Biochim Biophys Acta. 1981 Aug 24;665(2):317–321. doi: 10.1016/0005-2760(81)90016-3. [DOI] [PubMed] [Google Scholar]
  22. Vilaró S., Llobera M., Bengtsson-Olivecrona G., Olivecrona T. Lipoprotein lipase uptake by the liver: localization, turnover, and metabolic role. Am J Physiol. 1988 May;254(5 Pt 1):G711–G722. doi: 10.1152/ajpgi.1988.254.5.G711. [DOI] [PubMed] [Google Scholar]
  23. Wallinder L., Bengtsson G., Olivecrona T. Rapid removal to the liver of intravenously injected lipoprotein lipase. Biochim Biophys Acta. 1979 Oct 26;575(1):166–173. doi: 10.1016/0005-2760(79)90142-5. [DOI] [PubMed] [Google Scholar]
  24. Weintraub M., Rassin T., Eisenberg S., Ringel Y., Grosskopf I., Iaina A., Charach G., Liron M., Rubinstein A. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. J Lipid Res. 1994 Feb;35(2):229–238. [PubMed] [Google Scholar]
  25. Wing D. R., Fielding C. J., Robinson D. S. The effect of cycloheximide on tissue clearing-factor lipase activity. Biochem J. 1967 Sep;104(3):45C–46C. doi: 10.1042/bj1040045c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van Tilbeurgh H., Roussel A., Lalouel J. M., Cambillau C. Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis. J Biol Chem. 1994 Feb 11;269(6):4626–4633. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES